» Articles » PMID: 33364048

Role of Pyroptosis in Spinal Cord Injury and Its Therapeutic Implications

Overview
Journal J Adv Res
Date 2020 Dec 28
PMID 33364048
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Currently, spinal cord injury (SCI) is a pathological incident that triggers several neuropathological conditions, leading to the initiation of neuronal damage with several pro-inflammatory mediators' release. However, pyroptosis is recognized as a new programmed cell death mechanism regulated by the stimulation of caspase-1 and/or caspase-11/-4/-5 signaling pathways with a series of inflammatory responses.

Aim: Our current review concisely summarizes the potential role of pyroptosis-regulated programmed cell death in SCI, according to several molecular and pathophysiological mechanisms. This review also highlights the targeting of pyroptosis signaling pathways and inflammasome components and its therapeutic implications for the treatment of SCI.

Key Scientific Concepts: Multiple pieces of evidence have illustrated that pyroptosis plays significant roles in cell swelling, plasma membrane lysis, chromatin fragmentation and intracellular pro-inflammatory factors including IL-18 and IL-1β release. In addition, pyroptosis is directly mediated by the recently discovered family of pore-forming protein known as GSDMD. Current investigations have documented that pyroptosis-regulated cell death plays a critical role in the pathogenesis of multiple neurological disorders as well as SCI. Our narrative article suggests that inhibiting the pyroptosis-regulated cell death and inflammasome components could be a promising therapeutic approach for the treatment of SCI in the near future.

Citing Articles

FOXO3-induced microRNA-128-3p promotes the progression of spinal cord injury in mice via regulating NLRP3 inflammasome-mediated pyroptosis.

Yang S, Guan Y, Zheng C, Xia X, Ma X, Jiang J Front Immunol. 2025; 16:1526721.

PMID: 40061945 PMC: 11885150. DOI: 10.3389/fimmu.2025.1526721.


Macrophage polarization-related gene SOAT1 is involved in inflammatory response and functional recovery after spinal cord injury.

Peng P, Wang H, Pang Z, Zhang H, Hu S, Ma X Mol Cell Biochem. 2025; .

PMID: 40050510 DOI: 10.1007/s11010-025-05246-7.


Bioinformatics analysis of genes associated with disulfidptosis in spinal cord injury.

Wang S, Liu X, Tian J, Liu S, Ke L, Zhang S PLoS One. 2025; 20(2):e0318016.

PMID: 39951434 PMC: 11828381. DOI: 10.1371/journal.pone.0318016.


Long-read sequencing of 945 Han individuals identifies structural variants associated with phenotypic diversity and disease susceptibility.

Gong J, Sun H, Wang K, Zhao Y, Huang Y, Chen Q Nat Commun. 2025; 16(1):1494.

PMID: 39929826 PMC: 11811171. DOI: 10.1038/s41467-025-56661-9.


HSPA1A inhibits pyroptosis and neuroinflammation after spinal cord injury via DUSP1 inhibition of the MAPK signaling pathway.

He X, Deng B, Zhang C, Zhang G, Yang F, Zhu D Mol Med. 2025; 31(1):53.

PMID: 39924492 PMC: 11809008. DOI: 10.1186/s10020-025-01086-9.


References
1.
Ishrat T, Mohamed I, Pillai B, Soliman S, Fouda A, Ergul A . Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol. 2014; 51(2):766-78. PMC: 4730955. DOI: 10.1007/s12035-014-8766-x. View

2.
Zhou Y, Wang X, Kan S, Ning G, Li Y, Yang B . Traumatic spinal cord injury in Tianjin, China: a single-center report of 354 cases. Spinal Cord. 2015; 54(9):670-4. DOI: 10.1038/sc.2015.173. View

3.
Dai W, Wang X, Teng H, Li C, Wang B, Wang J . Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats. Int Immunopharmacol. 2018; 66:215-223. DOI: 10.1016/j.intimp.2018.11.029. View

4.
McKenzie B, Dixit V, Power C . Fiery Cell Death: Pyroptosis in the Central Nervous System. Trends Neurosci. 2019; 43(1):55-73. DOI: 10.1016/j.tins.2019.11.005. View

5.
Villa A, Vegeto E, Poletti A, Maggi A . Estrogens, Neuroinflammation, and Neurodegeneration. Endocr Rev. 2016; 37(4):372-402. PMC: 4971309. DOI: 10.1210/er.2016-1007. View